CO-338-052: TRITON2: A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer Associated With Homologous Recombination Deficiency

February 18, 2019
https://clinicaltrials.gov/ct2/results?id=NCT02952534
Cancer - Genitourinary/ Prostate
Cancer, Prostate Cancer, Phase II, Phase 2, Male, TRITON2, Rucaparib, Castration-resistant
Open